Glutamine and glutathione at ICU admission in relation to outcome

Glutamine depletion is demonstrated to be an independent predictor of hospital mortality in ICU (intensive care unit) patients. Today glutamine supplementation is recommended to ICU patients on parenteral nutrition. In addition to glutamine, glutathione may be a limiting factor in ICU patients with MOF (multiple organ failure). To study the prevalence of glutamine and glutathione depletion an observational study was performed. The results were analysed in relation to mortality and the conventional predictors of mortality outcome, APACHE II (Acute Physiology and Chronic Health Evaluation II) and SOFA (Sequential Organ Failure Assessment). Consecutive patients admitted to the ICU at Karolinska University Hospital Huddinge were studied. Patient admission scoring of APACHE II and SOFA were registered as well as mortality up to 6 months. Plasma glutamine concentration and whole blood glutathione status at admittance were analysed. The admission plasma glutamine concentrations were totally independent of the conventional risk scoring at admittance, and a subnormal concentration was an independent predictor of mortality. In addition, glutathione redox status was also an independent mortality predictor, but here a normal ratio was the risk factor. In both cases the mortality risk was mainly confined to the post-ICU period. A low plasma concentration of glutamine at ICU admission is an independent risk factor for post-ICU mortality. The possible benefit of extending glutamine supplementation post-ICU should be evaluated prospectively.

[1]  V. Pettilä,et al.  Scandinavian glutamine trial: a pragmatic multi‐centre randomised clinical trial of intensive care unit patients , 2011, Acta anaesthesiologica Scandinavica.

[2]  G. Hardy,et al.  Serum selenium and glutathione peroxidase-3 activity: biomarkers of systemic inflammation in the critically ill? , 2009, Intensive Care Medicine.

[3]  J. Wernerman,et al.  Glutamine kinetics during intravenous glutamine supplementation in ICU patients on continuous renal replacement therapy , 2007, Intensive Care Medicine.

[4]  U. Ungerstedt,et al.  Intravenous glutamine supplementation to head trauma patients leaves cerebral glutamate concentration unaffected , 2006, Intensive Care Medicine.

[5]  C. Rose,et al.  Interorgan ammonia, glutamate, and glutamine trafficking in pigs with acute liver failure. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[6]  J. Wernerman,et al.  Elimination kinetics of L-alanyl-L-glutamine in ICU patients , 2005, Amino Acids.

[7]  J. Wernerman,et al.  Temporal changes in whole-blood and plasma glutathione in ICU patients with multiple organ failure , 2005, Intensive Care Medicine.

[8]  J. Wernerman,et al.  Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients , 2004, Intensive Care Medicine.

[9]  J. Wernerman.  Glutamine to intensive care unit patients. , 2003, JPEN. Journal of parenteral and enteral nutrition.

[10]  J. Wernerman,et al.  Glutamine attenuates post-traumatic glutathione depletion in human muscle. , 2003, Clinical science.

[11]  H. Barle,et al.  Longitudinal pattern of glutamine/glutamate balance across the leg in long-stay intensive care unit patients. , 2002, Clinical nutrition.

[12]  P. Stehle,et al.  Parenteral l-alanyl-l-glutamine improves 6-month outcome in critically ill patients* , 2002, Critical care medicine.

[13]  D. Zurakowski,et al.  Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients , 2001, Critical care medicine.

[14]  A. Wagenmakers,et al.  Glutamine appearance rate in plasma is not increased after gastrointestinal surgery in humans. , 2000, The Journal of nutrition.

[15]  P. Ott,et al.  Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. , 2000, Gastroenterology.

[16]  M. Kretzschmar,et al.  Plasma levels of glutathione, α-tocopherol and lipid peroxides in polytraumatized patients; evidence for a stimulating effect of TNF α on glutathione synthesis , 1998 .

[17]  K. Andersson,et al.  Surgical trauma decreases glutathione synthetic capacity in human skeletal muscle tissue. , 1998, The American journal of physiology.

[18]  R. Griffiths,et al.  Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. , 1997, Nutrition.

[19]  G. L. Bolt.  “Bolus Injection” , 1969 .

[20]  Dean P. Jones,et al.  Depletion of plasma antioxidants in surgical intensive care unit patients requiring parenteral feeding: effects of parenteral nutrition with or without alanyl-glutamine dipeptide supplementation. , 2008, Nutrition.

[21]  H. O. Oudemans-van Straaten,et al.  Plasma glutamine depletion and patient outcome in acute ICU admissions , 2001, Intensive Care Medicine.